Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;49(7):653-61.
doi: 10.1002/mc.20635.

New outbred colony derived from Mus musculus castaneus to identify skin tumor susceptibility loci

Affiliations

New outbred colony derived from Mus musculus castaneus to identify skin tumor susceptibility loci

Kyoko Fujiwara et al. Mol Carcinog. 2010 Jul.

Abstract

Susceptibility to tumor development varies among mice strains. Using inbred NIH and wild-derived outbred Mus spretus backcrosses, skin cancer-susceptibility loci were mapped [Nagase et al. 1995. Nat Genet 10: 424-429; Nagase et al. 1999. Proc Natl Acad Sci USA 96: 15032-15037], and Skts13 was identified as the Aurka gene using a conventional linkage in conjunction with haplotype analysis [Ewart-Toland et al. 2003. Nat Genet 34: 403-412]. In the present study, we examined another wild-derived outbred Mus musculus castaneus in which 10.3% of the analyzed SNPs showed heterogeneity among the colony. All mice examined were completely resistant to the two-stage skin carcinogenesis protocol using 7.12-dimethylbenz(a)anthracene (DMBA)/12-O-tetradecanoylphorbol-13-acetate (TPA), and this resistant phenotype was dominant when we crossed them with the highly susceptible strain FVB. By scanning F1 backcross progeny between M. m. castaneus and FVB, we found a highly significant linkage for tumor multiplicity on Chromosome 4, which was overlapped with the Skts-fp1 locus, found in the previous study using FVB and PWK cross [Fujiwara et al. 2007. BMC Genet 8: 39]. The linkage was observed in all pedigrees from the five F1 founders, while the linkage for papilloma size on Chromosome 4 was mapped only in pedigrees from founders 1 and 2. By scanning the whole Chromosome 4 of the five F1 founders, founders 1- and 2-specific haplotype block was found between D4Mit293 (20.6 Mbp) and D4Mit171 (22.4 Mbp). In this study we exploited the outbred nature of M. m. castaneus stock to identify a haplotype contributing to papilloma size on mouse Chromosome 4. These data illustrate the strength of using outbred mice in identification of the genetic component of a mouse complex trait such as the skin cancer-susceptibility phenotype.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Whole-genome scan of 93 FxFC backcross mice. (A) Interval mapping revealed highly significant linkage on chromosome 4 and suggestive linkage on chromosomes 3 and 12 for papilloma multiplicity 20 weeks after initiation. Dashed line indicates empirical suggestive (P<0.63), significant (P<0.05) and highly significant (P<0.01) linkages of LOD score at 1.6, 3 and 3.5, respectively. (B) Interval mapping revealed suggestive linkage on chromosomes 4, 5 and 8 for average papilloma size 20 weeks after initiation. Dashed line indicates empirical suggestive linkage (P<0.63) of LOD score at 1.6.
Figure 1
Figure 1
Whole-genome scan of 93 FxFC backcross mice. (A) Interval mapping revealed highly significant linkage on chromosome 4 and suggestive linkage on chromosomes 3 and 12 for papilloma multiplicity 20 weeks after initiation. Dashed line indicates empirical suggestive (P<0.63), significant (P<0.05) and highly significant (P<0.01) linkages of LOD score at 1.6, 3 and 3.5, respectively. (B) Interval mapping revealed suggestive linkage on chromosomes 4, 5 and 8 for average papilloma size 20 weeks after initiation. Dashed line indicates empirical suggestive linkage (P<0.63) of LOD score at 1.6.
Figure 2
Figure 2
Interval mapping for papilloma multiplicity QTL on chromosome 4. By analyzing 218 FxFC backcross mice, the highly significant linkage for papilloma multiplicity 20 weeks after initiation was mapped on chromosome 4 (black line). Dark gray indicates the linkage calculated for founders 1 and 2, right; gray is for founders 3, 4 and 5. Physical position (Mbp) of each marker is shown on the bottom.
Figure 3
Figure 3
Interval mapping for papilloma size QTL on chromosome 4. By analyzing 218 FxFC backcross mice, the highly significant linkage for the average papilloma size 20 weeks after initiation was mapped on chromosome 4 (black line). Dark gray indicates the linkage calculated for founders 1 and 2, light gray is for founders 3, 4 and 5. Physical position (Mbp) of each marker is shown on the bottom.
Figure 4
Figure 4
Haplotype map of FC founders on whole Chromosome 4. (A) Five FC founders and FVB were genotyped using 169 microsatellite markers. Genotype data of Castaneus allele in each FC founder was shown as polymorphic allele ID. (B) Region between D4Mit293 and D4Mit171 is genotyped using additional SNP markers.

Similar articles

Cited by

References

    1. Nagase H, Bryson S, Cordell H, Kemp CJ, Fee F, Balmain A. Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat Genet. 1995;10:424–429. - PubMed
    1. Nagase H, Mao JH, Balmain A. A subset of skin tumor modifier loci determines survival time of tumor-bearing mice. Proc Natl Acad Sci USA. 1999;96:15032–15037. - PMC - PubMed
    1. Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F, MacCarthy-Morrogh L, Ponder BA, Nagase H, Burn J, Ball S, Almeida M, Linardopoulos S, Balmain A. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet. 2003;34:403–412. - PubMed
    1. Fujiwara K, Igarashi J, Irahara N, Kimura M, Nagase H. New chemically induced skin tumour susceptibility loci identified in a mouse backcross between FVB and dominant resistant PWK. BMC Genet. 2007;8:39. - PMC - PubMed
    1. Li FP. Identification and management of inherited cancer susceptibility. Environ Health Perspect. 1995;103 (Suppl 8):297–300. - PMC - PubMed

Publication types